
While people with type 1 diabetes can see some benefit from newer medications prescribed off-label, there is also risk, and these patients should be monitored closely, according to a new study. Type 1 diabetes is universally treated with insulin injections, but only about one-fifth of patients achieve blood sugar control with it, the study authors… read on > read on >